MagneGas Invited to United Nations Ebola Crisis Response Meeting
Company Presenting Use of MagneGas Technology as Possible Treatment of Ebola Contaminated Medical Waste
TAMPA, Fla., Dec. 8, 2014 /PRNewswire/ -- MagneGas Corporation ("MagneGas" or the "Company") (NASDAQ: MNGA), a technology company that counts among its inventions a patented process that converts liquid waste into a hydrogen-based fuel, announced today that it has been invited to participate at the United Nations Ebola Crisis Response high-level meetings being held on Thursday, December 11, 2014 at the United Nations headquarters in New York City.
The meetings are being held by the United Nations Global Compact, the United Nations Mission for Ebola Emergency Response ("UNMEER"), and the Ebola Private Sector Mobilization Group. This assembly consists of a coalition of over 35 companies with major assets and operations in West Africa mobilizing business resources to support front-line Ebola humanitarian relief efforts while also advocating for a more concerted global response to the Ebola outbreak and recovery.
The Company will be discussing the potential use of the MagneGas technology to treat medical waste and sewage related to the Ebola outbreak in West Africa. MagneGas believes, based on past successful sterilization of highly contaminated liquid waste, that the high temperature of the Plasma Arc system will fully sterilize bio-contaminated human waste. In addition, due to the extremely high flame temperature of the MagneGas® fuel, the Company believes that the use of its fuel for co-incineration with existing systems, will increase heat output and reduce emissions further sterilizing waste as an alternative treatment option. In addition, the Company also has available a trailer mounted Plasma Arc system that can be deployed quickly and operated on a local diesel generator.
"The Company has been working for many years, both in Europe and the United States, testing the use of the MagneGas technology to sterilize waste with extremely high levels of bio-contaminants. It has been demonstrated that the exposure of bio-contaminants to our 12,000F degree electric arc renders the waste fully sterilized without the need for any chemical additives or use of other methods. We believe that this process will have a similar effect on Ebola contaminated medical waste. We are honored and humbled by the opportunity to participate in these extremely important meetings that will shape the future success of the Ebola outbreak containment. Anything that we can do to help reduce the outbreak by limiting contaminant proliferation would be extremely important to the MagneGas family," stated MagneGas CEO Ermanno Santilli.
About MagneGas Corporation
Founded in 2007, Tampa-based MagneGas Corporation (NASDAQ: MNGA) is a technology Company that counts among its inventions, a patented process that converts liquid waste into hydrogen based fuels. The Company currently sells MagneGas® into the metal working market as a replacement to acetylene. It is also selling equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets. In addition, the Company is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature for co-combustion of hydrocarbon fuels and other advanced applications. For more information on MagneGas®, please visit the Company's website at www.MagneGas.com.
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/magnegas-invited-to-united-nations-ebola-crisis-response-meeting-300005910.html
SOURCE MagneGas Corporation
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article